Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Martolini, R. Tanner, D. Shrikrishna, C. Davey, C. Smith, M. Patel, Z. Zoumot, A. Donaldson, D. Mohan, G. Coissi, S. Clark, D. Elia, P. Palange, N. Hopkinson, M. I. Polkey (London, United Kingdom; Rome, Italy). Impact of a patent foramen ovale (PFO) presence in patients with GOLD stage II chronic obstructive pulmonary disease (COPD). Eur Respir J 2012; 40: Suppl. 56, 250

Member's Comments

No comment yet.

Related content which might interest you: The prevalence of patent foramen ovale in chronic obstructive pulmonary disease patients with increased pulmonary hypertension Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 The influence of patent foramen ovale on oxygen desaturation in obstructive sleep apnoea Source: Eur Respir J 2007; 29: 149-155 Year: 2007 Model of staged development chronic obstructive pulmonary disease (COPD) in rats Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011 The state of patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 547s Year: 2007 An early prediction of intravascular microthromb formation for patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Five years outcome of Karakoca Resector Balloon dilalation and curetage method in Severe COPD (chronic obstructive pulmonary disease ) Source: International Congress 2018 – Endoscopic lung volume reduction Year: 2018 Benefits of pulmonary rehabilitation (PR) in patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) having the same dyspnoea severity Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018 Prevalence of chronic obstructive pulmonary disease (COPD) among smokers with stable coronary artery disease (CAD) Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Comparison of CT scan-measured pulmonary artery to aorta ratio of combined pulmonary fibrosis and emphysema (CPFE) and COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Influence of bronchodilators on pulmonary hypertension (PH) in patients with moderate and severe chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 310s Year: 2005 Predictors of arrhythmias in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Place of the residual volume in the diagnosis of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - New or old physiological parameters in chronic airway disorders? Year: 2010 Prognostic impact of chronic obstructive pulmonary disease in severe symptomatic aortic stenosis Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016 Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Prognosis after non-invasive ventiltation (NIV) for chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Recent advances in noninvasive ventilation used for treating acute respiratory failure Year: 2011 Chronic obstructive pulmonary disease (COPD) patients with bronchiectasis: clinical features? Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Awareness of chronic obstructive pulmonary disease (COPD) in Portugal Source: Eur Respir J 2007; 30: Suppl. 51, 126s Year: 2007 Lung volume response to bronchodilators is dependent on the stage of the disease in chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2006 - COPD therapy Year: 2006 The metabolic syndrome (MetS) in patients with chronic obstructive pulmonary disease (COPD) and its association with airway obstruction Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012 Regional ventilatory defects in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2006 - COPD: imaging and computer applications Year: 2006